Gilead CEO exercises 8,780 RSUs, shares withheld
Gilead Sciences’ CEO exercised 8,780 RSUs into common shares, with part of the stock withheld to cover exercise price or tax obligations and 83,300 RSUs remaining outstanding.
Rhea-AI Filing Summary
GILEAD SCIENCES, INC. (GILD) reported that Chairman & CEO Daniel Patrick O'Day exercised restricted stock units into common stock on September 10, 2026. The transaction involved 8,780 restricted stock units converting into 8,780 shares of common stock, with 4,230 shares delivered or withheld for payment of exercise price or tax liability. Following the derivative transaction, 83,300 restricted stock units remained outstanding, subject to a four-year vesting schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary
8,780 shares exercised/converted
Exercise
3 txns
Insider
O'Day Daniel Patrick
Role
Chairman & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 8,780 | -- | -- |
| Exercise | Common Stock F1 | 8,780 | -- | -- |
| Exercise Price or Tax Liability | Common Stock | 4,230 | $144.81 | $613K |
Holdings After Transaction:
Restricted Stock Unit — 83,300 contracts (Direct);
Common Stock — 581,683 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- F2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Key Figures
Restricted stock units exercised: 8,780 units
Common shares delivered/withheld: 4,230 shares
Price per share for payment transaction: $144.81 per share
+3 more
6 metrics
Restricted stock units exercised
8,780 units
RSUs converted into common stock on September 10, 2026
Common shares delivered/withheld
4,230 shares
Shares delivered or withheld for payment of exercise price or tax liability
Price per share for payment transaction
$144.81 per share
Used to value the 4,230-share payment-of-obligation transaction
RSUs remaining after transaction
83,300 units
Restricted stock units directly owned following the derivative transaction
Initial vesting tranche
25.0%
Portion of RSUs that vest on the first anniversary of the grant date
Ongoing quarterly vesting rate
6.25% per quarter
Quarterly vesting rate after the first anniversary until fully vested
Key Terms
Restricted Stock Unit, vesting schedule, tax liability, Rule 10b5-1
4 terms
Restricted Stock Unit financial
"Each restricted stock unit represents the contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
vesting schedule financial
"The restricted stock units have a 4-year vesting schedule"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
Rule 10b5-1 regulatory
"The filing’s Rule 10b5-1 checkbox is not marked as affirmative"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did GILD report for Daniel O'Day on September 10, 2026?
Gilead Sciences reported that Chairman & CEO Daniel O'Day exercised 8,780 restricted stock units into 8,780 shares of common stock on September 10, 2026, with a portion of the resulting shares delivered or withheld for payment of exercise price or tax liability.
How many GILD restricted stock units did Daniel O'Day convert and what remained?
Daniel O'Day converted 8,780 restricted stock units into common stock. After this exercise, 83,300 restricted stock units remained directly owned, according to the filing’s post-transaction derivative holdings figure.
What is the vesting schedule of Daniel O'Day’s GILD restricted stock units?
The restricted stock units have a four-year vesting schedule: 25% vest on the first anniversary of the grant date, and the remaining balance vests at 6.25% quarterly thereafter until fully vested.
Were Daniel O'Day’s GILD transactions made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the footnotes do not state use of a Rule 10b5-1 plan, so no Rule 10b5-1 trading plan is reported for these transactions.
What types of GILD securities are involved in Daniel O'Day’s Form 4?
The Form 4 involves restricted stock units that each represent the contingent right to receive one share of Gilead common stock, and the resulting common stock issued upon exercise, some of which were delivered or withheld for payment obligations.
AI-generated analysis. How Rhea-AI works. Not financial advice.
